Boehringer Ingelheim launches Vaxxilive Cocci 3, a cutting-edge poultry coccidiosis vaccine (formerly Hatchpak Cocci III). This biological alternative stimulates the bird’s natural immune response, minimizing tissue damage. VAXXILIVE COCCI 3 contains proven precocious strains for early immunity, reducing oocyst production. Its improved formula allows year-round use, minimizing chemical resistance. Boehringer enhances manufacturing processes for consistent quality.
Rick Phillips, DVM, director, Key Account Veterinarians, emphasizes the importance of product selection and highlights Boehringer's field team's support in creating comprehensive poultry health programs. VAXXILIVE COCCI 3 is now available; consult your flock veterinarian or Boehringer representative.
For more information, visit https://bi-animalhealth.com/.
